Cutaneous Cryptococcus in a nonimmunocompromised host

Infectious Diseases in Clinical Practice

Volumn 6, Issue 6, 1997, Pages 410-413

  Burlage, Ann M ^a   Fuller, Peggy ^a   Mikolich, Dennis J ^b   Weinstock, Martin A ^b  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOXACILLIN; FLUCONAZOLE;

AGED; ARTICLE; CASE REPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SKIN; SKIN BIOPSY;

EID: 0030733286     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199706060-00013     Document Type: Article

References (19)

1. Noble R, Fajardo L. Primary cutaneous Cryptococcus. Am J Clin Pathol 1972;57: 13-22.
2. Schupbach CW, Wheeler CE, Briggaman RA, et al. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 1976; 112:1734-40.
3. Antony S, Suresh J. Primary cutaneous Cryptococcus in nonimmunocompromised Patients. Cutis 1995:96-8.
4. Diamond RD. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed New York: Churchill Livingston, 1995: 2331-40
5. Haight DO, Esperanza LE, Greene JN, et al. Case report: cutaneous manifestations of cryptococcosis. Am J Med Sci 1994;308: 192-5.
6. Iacobellis FW, Jacobs MI, Cohen RP. Primary cutaneous Cryptococcus. Arch Dermatol 1979,115:984-5.
7. Rook A, Woods B. Cutaneous Cryptococcus. Br J Dermatol 1962;74:43-9.
8. Moore M. Cryptococcus with cutaneous manifestations J Invest Dermatol 1957,28:159-82
9. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis. Arch Dermatol 1971;104: 1-3.
10. Sussman EJ, McMahon F, Wright D, Fnedman HM. Cutaneous cryptococcosis without evidence of systemic involvement. J Am Acad Dermatol 1984,11:371-4.
11. Chu AC, Hay RJ, MacDonald DM. Cutaneous cryptococcosis. Br J Dermatol 1980;103: 95-100.
12. Schuttleworth D, Philpot CM, Knight AG. Cutaneous Cryptococcus; treatment with fluconazole. Br J Dermatol 1989;120:683-7.
13. Shrader SK, Watts JC, Danick JA, et al. Disseminated Cryptococcus presenting as cellulitis with necrotizing variculae. J Clin Microbiol 1986;24 860-2.
14. 450 sterol synthesis and metabolism: differences between fluconazole and other azoles. In: Fromtling RA, editor. Trends in the discovery, development, and evaluation of fungal agents. Barcelona: Prous, 1987.
15. Como JA, Dismukes WE. Oral azole drugs as systemic therapy. N Engl J Med 1994;330: 263-72
16. Berry AJ, Rinaldi MG, Graybill JR. Use of high dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992, 36:690-2.
17. Goonetilleke AKE, Kranse K, Slater DN, et al. Primary cutaneous cryptococcosis in an immunocompromised pigeon keeper Br J Dermatol 1995;133.650-2.
18. Song IC, Hunter JG Primary cutaneous cryptococcosis as a presenting manifestation of AIDS Plast Reconstr Surg 1992,90 1065-7.
19. Cusini M, Cagliani P, Grimait R, et al. Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 1991;127:1848-9.